HealthTech company Advanced Health Intelligence (ASX: AHI) is set to launch a medically-approved mobile phone-based atrial fibrillation (AF) assessment in Q2 CY24 in collaboration with Belgium-based Qompium NV, a company specialising in mobile scanning tech. Globally, there are about 60 million cases of atrial fibrillation (AF), which is a form of arrhythmia involving irregular heartbeat.
Read More
With its cash reserves dwindling, digital health company Advanced Health Intelligence (ASX: AHI) is having to make a strong case for itself among shareholders. One of its bigger moves is the US FDA submission of July 2023. The purpose of an FDA Section 513(g) submission is to obtain clarification on the regulatory pathway for a
Read More
Traditionally, underwriting for health insurance involves conducting blood tests and other examinations to understand how much insurers can afford. However, this process tends to be slow and costly, thus needing a better alternative. That’s where digital healthcare company Advanced Health Intelligence (ASX: AHI) comes in. The Company has entered a Letter of Intent (LOI) with
Read More
